This inventor holds 1 USPTO granted patent. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Richard Y Bae: Innovator in Ultrasound Imaging Technology
Introduction
Richard Y Bae is a notable inventor based in Rochester, MN (US). He has made significant contributions to the field of ultrasound imaging, particularly in the detection of contrast agents within the human body. His innovative approach has the potential to enhance diagnostic capabilities in medical imaging.
Latest Patents
Richard Y Bae holds a patent for a method and apparatus for recovery and parametric display of contrast agents in ultrasound imaging. This patent describes a method for detecting the presence of contrast agents in a patient's body by initially transmitting ultrasound pulses along respective acoustic scan lines. These pulses exhibit a fundamental transmission frequency. A set of returned signals is received along each scan line after each pulse transmission. The return signals are mathematically reconstructed to provide a first spectral component around the fundamental frequency and a second spectral component around a harmonic frequency. The peak amplitude of the reconstructed spectral components is compared to determine whether a contrast agent is present in the tissue, allowing for differentiation between myocardium and perfused myocardium.
Career Highlights
Richard Y Bae is associated with the Mayo Foundation for Medical Education and Research, where he continues to advance his research and innovations in medical imaging technology. His work is instrumental in improving the accuracy and effectiveness of ultrasound diagnostics.
Collaborations
Richard collaborates with Marek Belohlavek, contributing to the development of advanced ultrasound imaging techniques.
Conclusion
Richard Y Bae's contributions to ultrasound imaging technology exemplify the impact of innovation in the medical field. His patent reflects a significant advancement in the detection of contrast agents, which can lead to improved patient outcomes.
